Take heed to this text
![A version of Endiatx’s PillBot as of June 2024. | Source: Endiatx.](https://www.therobotreport.com/wp-content/uploads/2024/06/Endiatx-PillBot-June-2024-768x499-1.jpeg)
A model of Endiatx’s PillBot as of June 2024. | Supply: Endiatx
Endiatx LLC is planning a pivotal trial for its swallowable, steerable Pillbot robotic digital camera at Mayo Clinic campuses this 12 months.
The Hayward, Calif.–based mostly startup advised MassDevice this week that it has already began its first in-human trials in New Zealand. Endiatx mentioned that it plans to publish information from these trials and that they’re “progressing nicely, and physicians recognize the expertise.”
The corporate added that it intends to file for an investigational system exemption (IDE) from the U.S. Meals and Drug Administration this 12 months to begin the pivotal trial, to be carried out at Mayo Clinic campuses. It additionally supplied an replace on its fundraising, saying it has already secured $7 million from buyers and is engaged on a $20 million Collection A spherical.
Endiatx co-founder and CEO Torrey Smith mentioned the most recent model of PillBot has new optics with a 160° subject of view (see video).
PillBot Model 1.0 has a 13 mm (0.5 in.) diameter and wi-fi distant management so a doctor can transfer the swallowable system round inside a affected person’s abdomen for visible inspection.
Endiatx envisions PillBot 2.0 as smaller, with 10 mm diameter and “AI-automated motion, lab-on-chip gut-biome evaluation, additional miniaturization, [and] AI diagnostics utilizing giant information pool.”
Later iterations may embody surgical instruments, Smith advised Medical Design & Outsourcing (MDO, a sibling website to The Robotic Report) in 2022.
![Endiatx co-founder and CEO Torrey Smith with PillBot.](https://www.therobotreport.com/wp-content/uploads/2024/06/Endiatx-CEO-Torrey-Smith-and-PillBot-768x499-1.webp)
Endiatx co-founder and CEO Torrey Smith with PillBot. | Supply: Hardy Wilson for MDO
Endiatx partnership with Mayo Clinic continues
Rochester, Minn.-based Mayo Clinic already has fairness in Endiatx by way of a 15-year know-how license settlement masking the system’s growth.
Dr. Vivek Kumbhari, the chair of gastroenterology and hepatology at Mayo Clinic–Florida, joined the Endiatx board in 2021 and helped Endiatx with cadaver testing at Mayo Clinic.
Most lately, Kumbhari introduced a TED Speak in April with Alex Luebke, co-founder, chair, and chief expertise officer of Endiatx, who swallowed a PillBot reside on stage. That TED Speak went reside simply this week — watch it under:
Endiatx CEO to keynote RoboBusiness
Smith will likely be keynoting RoboBusiness 2024, which takes place on the Santa Clara Conference Middle on Oct. 16 and 17. Through the keynote, Smith will give a reside demo of Endiatx’s swallowable robotic tablet.
RoboBusiness is the premier occasion for industrial robotics builders. Attendees will achieve the most recent insights from specialists in robotics and AI on cutting-edge analysis, business tendencies, and progressive purposes. They’ll additionally study investments and subjects associated to working a robotics enterprise.
With greater than 150 exhibitors on the present ground, there will likely be loads of alternatives and particular occasions for robotics business professionals to share insights, have fun successes, overcome challenges, and extra. The improved present ground will embody new options comparable to a Robotics Startup Zone, an Engineering Theater, and extra.
RoboBusiness will likely be co-located with DeviceTalks West, the premier business occasion for medical expertise professionals. DeviceTalks West attracts engineering and enterprise professionals from a broad vary of healthcare and medical expertise backgrounds, together with surgical robotics.
Editor’s observe: This text was syndicated from The Robotic Report sibling website MassDevice.